Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1eb9667071f40bd09df47436437f0651 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 |
filingDate |
2007-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7523e1f73c44a0dd9a9788468d315f67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c104e8eb73a608ecd7a6bd3f1e8ba3ac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_770917cf99109de89cb7bac9fce32c13 |
publicationDate |
2009-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2019675-A1 |
titleOfInvention |
Methods for treating or preventing neoplasias |
abstract |
The present invention is directed to a method for treating or preventing a neoplasia in a human patient in need of such treatment comprising administering to the patient a compound that inhibits microsomal prostaglandin E synthase-1 in an amount that is effective for treating or preventing the neoplasia. |
priorityDate |
2006-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |